IDEXX Laboratories, Inc. IDXX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.86% | 9.66% | 14.26% | 14.28% | 13.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.86% | 9.66% | 14.26% | 14.28% | 13.29% |
| Cost of Revenue | 6.65% | 5.49% | 11.47% | 12.73% | 11.17% |
| Gross Profit | 11.85% | 12.14% | 15.94% | 15.33% | 14.65% |
| SG&A Expenses | 10.58% | 10.90% | 14.64% | 6.14% | 11.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.20% | 7.42% | 12.64% | 10.59% | 11.72% |
| Operating Income | 13.39% | 14.08% | 17.90% | 24.04% | 16.77% |
| Income Before Tax | 15.82% | 15.14% | 14.63% | 19.73% | 15.34% |
| Income Tax Expenses | 17.13% | 15.28% | 14.23% | 46.12% | 6.20% |
| Earnings from Continuing Operations | 15.49% | 15.11% | 14.74% | 14.82% | 17.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.49% | 15.11% | 14.74% | 14.82% | 17.94% |
| EBIT | 13.39% | 14.08% | 17.90% | 24.04% | 16.77% |
| EBITDA | 13.14% | 14.14% | 17.18% | 23.00% | 15.81% |
| EPS Basic | 17.35% | 17.24% | 17.15% | 17.62% | 21.19% |
| Normalized Basic EPS | 16.67% | 16.93% | 20.53% | 26.25% | 18.52% |
| EPS Diluted | 17.94% | 17.63% | 17.23% | 17.88% | 21.43% |
| Normalized Diluted EPS | 17.18% | 17.24% | 20.65% | 26.40% | 18.75% |
| Average Basic Shares Outstanding | -1.59% | -1.81% | -2.05% | -2.38% | -2.68% |
| Average Diluted Shares Outstanding | -2.02% | -2.08% | -2.15% | -2.49% | -2.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |